Invitae to Present Data at the American Society of Human Genetics Annual Meeting Furthering the Understanding of Variants of Uncertain Significance in Underrepresented Populations

– Presentations provide additional insights into the critical importance of advancing equity in genomics – SAN FRANCISCO, Oct. 28, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, will present data from its genetic testing portfolio at the American Society of...

Click to view original post